http://purl.org/np/RAehpcNn0nah9FggbaYf4ng8lDHy139nL7nACQhm3Z8dk#Head http://purl.org/np/RAehpcNn0nah9FggbaYf4ng8lDHy139nL7nACQhm3Z8dk http://www.nanopub.org/nschema#hasAssertion http://purl.org/np/RAehpcNn0nah9FggbaYf4ng8lDHy139nL7nACQhm3Z8dk#assertion http://purl.org/np/RAehpcNn0nah9FggbaYf4ng8lDHy139nL7nACQhm3Z8dk http://www.nanopub.org/nschema#hasProvenance http://purl.org/np/RAehpcNn0nah9FggbaYf4ng8lDHy139nL7nACQhm3Z8dk#provenance http://purl.org/np/RAehpcNn0nah9FggbaYf4ng8lDHy139nL7nACQhm3Z8dk http://www.nanopub.org/nschema#hasPublicationInfo http://purl.org/np/RAehpcNn0nah9FggbaYf4ng8lDHy139nL7nACQhm3Z8dk#pubinfo http://purl.org/np/RAehpcNn0nah9FggbaYf4ng8lDHy139nL7nACQhm3Z8dk http://www.w3.org/1999/02/22-rdf-syntax-ns#type http://www.nanopub.org/nschema#Nanopublication http://purl.org/np/RAehpcNn0nah9FggbaYf4ng8lDHy139nL7nACQhm3Z8dk#assertion http://purl.obolibrary.org/obo/DOID_3890 https://w3id.org/biolink/vocab/category https://w3id.org/biolink/vocab/Disease http://purl.org/np/RAehpcNn0nah9FggbaYf4ng8lDHy139nL7nACQhm3Z8dk#association http://www.w3.org/1999/02/22-rdf-syntax-ns#object http://purl.obolibrary.org/obo/DOID_3890 http://purl.org/np/RAehpcNn0nah9FggbaYf4ng8lDHy139nL7nACQhm3Z8dk#association http://www.w3.org/1999/02/22-rdf-syntax-ns#predicate https://w3id.org/biolink/vocab/treats http://purl.org/np/RAehpcNn0nah9FggbaYf4ng8lDHy139nL7nACQhm3Z8dk#association http://www.w3.org/1999/02/22-rdf-syntax-ns#subject https://identifiers.org/drugbank:DB03404 http://purl.org/np/RAehpcNn0nah9FggbaYf4ng8lDHy139nL7nACQhm3Z8dk#association http://www.w3.org/1999/02/22-rdf-syntax-ns#type http://www.w3.org/1999/02/22-rdf-syntax-ns#Statement http://purl.org/np/RAehpcNn0nah9FggbaYf4ng8lDHy139nL7nACQhm3Z8dk#association http://www.w3.org/2000/01/rdf-schema#label panhematin is a hemin for injection indicated for the amelioration of recurrent attacks of acute intermittent porphyria temporally related to the menstrual cycle in susceptible women after initial carbohydrate therapy is known or suspected to be inadequate limitations of use see dosage and administration 2 1 panhematin is a hemin for injection indicated for amelioration of recurrent attacks of acute intermittent porphyria temporally related to the menstrual cycle in susceptible women after initial carbohydrate therapy is known or suspected to be inadequate 1 limitations of use 1 1 http://purl.org/np/RAehpcNn0nah9FggbaYf4ng8lDHy139nL7nACQhm3Z8dk#association https://w3id.org/biolink/vocab/association_type https://w3id.org/biolink/vocab/ChemicalToDiseaseOrPhenotypicFeatureAssociation http://purl.org/np/RAehpcNn0nah9FggbaYf4ng8lDHy139nL7nACQhm3Z8dk#association https://w3id.org/biolink/vocab/provided_by https://w3id.org/um/NeuroDKG http://purl.org/np/RAehpcNn0nah9FggbaYf4ng8lDHy139nL7nACQhm3Z8dk#association https://w3id.org/biolink/vocab/relation https://w3id.org/um/neurodkg/SymptomaticReliefIndication https://identifiers.org/drugbank:DB03404 https://w3id.org/biolink/vocab/category https://w3id.org/biolink/vocab/Drug http://purl.org/np/RAehpcNn0nah9FggbaYf4ng8lDHy139nL7nACQhm3Z8dk#provenance http://purl.org/np/RAehpcNn0nah9FggbaYf4ng8lDHy139nL7nACQhm3Z8dk#assertion http://www.w3.org/ns/prov#wasAttributedTo https://orcid.org/0000-0002-1468-3557 http://purl.org/np/RAehpcNn0nah9FggbaYf4ng8lDHy139nL7nACQhm3Z8dk#pubinfo http://purl.org/np/RAehpcNn0nah9FggbaYf4ng8lDHy139nL7nACQhm3Z8dk#sig http://purl.org/nanopub/x/hasAlgorithm RSA http://purl.org/np/RAehpcNn0nah9FggbaYf4ng8lDHy139nL7nACQhm3Z8dk#sig http://purl.org/nanopub/x/hasPublicKey MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCODwZkXojpEKwk7Ldj2oPPfCstvqrcpgCaTLo235K7ht9C7E1GCkLvUuL2b4VWXJTcZx/hxgDauR8hUeYq/lS6tfTL9yFZsnfl+PWYDyz7vv6N+wJVx2LL8bO6ntCjcOzvW2t2WUeF12Sb6b3I6uOYP0N8iQKts1WasY/yEYKAHQIDAQAB http://purl.org/np/RAehpcNn0nah9FggbaYf4ng8lDHy139nL7nACQhm3Z8dk#sig http://purl.org/nanopub/x/hasSignature hxfxyh/sIrYQJPe9p9pFo7WHjfTDqZ+dWlxILBHEzCcOZv/Ipf4ha0SHnT98fZ5wfTav1jKKlbXvmy6wWCZ1V1lliiXC9HLdcKzDwYeI5ewI6JY3yQ0JDH3+YJ+S74H3laYfabI03bcxqbZMWXwR8dmMRW8D1vtoq+Qx4hlVWFw= http://purl.org/np/RAehpcNn0nah9FggbaYf4ng8lDHy139nL7nACQhm3Z8dk#sig http://purl.org/nanopub/x/hasSignatureTarget http://purl.org/np/RAehpcNn0nah9FggbaYf4ng8lDHy139nL7nACQhm3Z8dk http://purl.org/np/RAehpcNn0nah9FggbaYf4ng8lDHy139nL7nACQhm3Z8dk http://purl.org/dc/terms/created 2021-07-03T15:46:34.917+02:00 http://purl.org/np/RAehpcNn0nah9FggbaYf4ng8lDHy139nL7nACQhm3Z8dk http://purl.org/dc/terms/creator https://orcid.org/0000-0002-1468-3557 http://purl.org/np/RAehpcNn0nah9FggbaYf4ng8lDHy139nL7nACQhm3Z8dk https://w3id.org/np/o/ntemplate/wasCreatedFromProvenanceTemplate http://purl.org/np/RANwQa4ICWS5SOjw7gp99nBpXBasapwtZF1fIM3H2gYTM http://purl.org/np/RAehpcNn0nah9FggbaYf4ng8lDHy139nL7nACQhm3Z8dk https://w3id.org/np/o/ntemplate/wasCreatedFromPubinfoTemplate http://purl.org/np/RAA2MfqdBCzmz9yVWjKLXNbyfBNcwsMmOqcNUxkk1maIM http://purl.org/np/RAehpcNn0nah9FggbaYf4ng8lDHy139nL7nACQhm3Z8dk https://w3id.org/np/o/ntemplate/wasCreatedFromTemplate http://purl.org/np/RAManV5GZI01JKzW_IPcfOXoiFTcZMmsV7qTCLkdzr4Gs